Drug-drug interaction mediated by inhibition and induction of P-glycoprotein

被引:234
作者
Lin, JH [1 ]
机构
[1] Merck Res Labs, Dept Drug Metab, West Point, PA 19486 USA
关键词
P-glycoprotein-mediated drug interactions; genetic polymorphism; saturable efflux transport; blood-brain barrier;
D O I
10.1016/S0169-409X(02)00171-0
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
P-glycoprotein (P-gp), the most extensively studied ATP-binding cassette transporter, functions as a biological barrier by extruding toxic substances and xenobiotics out of cells. In vitro and in vivo studies have demonstrated that P-gp plays a significant role in drug absorption and disposition. Like cytochrome P450 enzymes, inhibition and induction Of P7-gp have been reported as the causes of drug-drug interactions. Because many prototypic inhibitors and inducers affect both CYP3A4 and P-gp, many drug interactions caused by these inhibitors and inducers involve these two systems. Clinically, it is very difficult to quantitatively differentiate P-gp-mediated drug interactions versus CYP3A4-mediated drug interactions, unless their relative contributions can be accurately estimated. Therefore, care should be exercised when interpreting drug interaction data and exploring the underlying mechanisms of drug interactions. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:53 / 81
页数:29
相关论文
共 157 条
[61]   Transporters on demand - Intrahepatic pools of canalicular ATP binding cassette transporters in rat liver [J].
Kipp, H ;
Pichetshote, N ;
Arias, IM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (10) :7218-7224
[62]   Molecular pharmacology of organic cation transporters in kidney [J].
Koepsell, H ;
Gorboulev, V ;
Arndt, P .
JOURNAL OF MEMBRANE BIOLOGY, 1999, 167 (02) :103-117
[63]   Spinal cord bioavailability of methylprednisolone after intravenous and intrathecal administration - The role of P-glycoprotein [J].
Koszdin, KL ;
Shen, DD ;
Bernards, CM .
ANESTHESIOLOGY, 2000, 92 (01) :156-163
[64]   USE OF AREA UNDER CURVE TO ESTIMATE ABSOLUTE BIOAVAILABILITY OF DIGOXIN [J].
KRAMER, WG ;
REUNING, RH .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1978, 67 (01) :141-142
[65]   EXTRAHEPATIC METABOLISM OF DRUGS IN HUMANS [J].
KRISHNA, DR ;
KLOTZ, U .
CLINICAL PHARMACOKINETICS, 1994, 26 (02) :144-160
[66]   Placental P-glycoprotein deficiency enhances susceptibility to chemically induced birth defects in mice [J].
Lankas, GR ;
Wise, LD ;
Cartwright, ME ;
Pippert, T ;
Umbenhauer, DR .
REPRODUCTIVE TOXICOLOGY, 1998, 12 (04) :457-463
[67]   Incidence of adverse drug reactions in hospitalized patients - A meta-analysis of prospective studies [J].
Lazarou, J ;
Pomeranz, BH ;
Corey, PN .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (15) :1200-1205
[68]   Pregnane X receptor: molecular basis for species differences in CYP3A induction by xenobiotics [J].
LeCluyse, EL .
CHEMICO-BIOLOGICAL INTERACTIONS, 2001, 134 (03) :283-289
[69]   HIV-1 protease inhibitors and the MDR1 multidrug transporter [J].
Lee, CGL ;
Gottesman, MM .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (02) :287-288
[70]   Induction of P-glycoprotein mRNA transcripts by cycloheximide in animal tissues: Evidence that class I Pgp is transcriptionally regulated whereas class II Pgp is post-transcriptionally regulated [J].
Lee, CH .
MOLECULAR AND CELLULAR BIOCHEMISTRY, 2001, 216 (1-2) :103-110